Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115354 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mireia Moreno-Estellés und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-Instituto de Salud Carlos III, 46010 Valencia, Spain. Hauptthemen laut MEDLINE: Biomarkers, Lafora Disease, Cytokines, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, La Fundació La Marató TV3, Centre for Biomedical Network Research on Rare Diseases.
Abstract (Originalsprache)
Lafora progressive myoclonus epilepsy (LD, OMIM#254780, ORPHA:501) is an ultra-rare and severe autosomal recessive neurological disorder that typically manifests in early adolescence. It is characterized by the accumulation of insoluble forms of aberrant glycogen in the brain and peripheral tissues. Given the urgent need for reliable tools to monitor disease progression, we aimed to identify reliable biomarkers in minimally invasive fluids, which could also provide valuable insights into the natural history of the disease. Plasma-EDTA samples from eleven LD patients and healthy controls were analyzed to identify potential biomarkers of LD using a high-throughput assay. The findings were subsequently validated using specific enzyme-linked immunosorbent assays (ELISAs). Eleven cytokines and growth factors were identified to be significantly reduced in LD patient samples compared to healthy controls. Among these, four mediators [platelet-derived growth factor subunit B (PDGF-BB), epidermal growth factor (EGF), brain derived growth factor (BDNF), and macrophage migration inhibitory factor (MIF)] exhibited the greatest fold change between the groups and were further validated. Given the minimally invasive nature of plasma sampling and the straightforward quantification via ELISA assays, these biomarkers hold strong promise for rapid translation to the clinic, potentially enhancing early diagnosis and longitudinal disease monitoring in LD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-Instituto de Salud Carlos III, 46010 Valencia, Spain.
- Instituto de Biomedicina de Valencia, CSIC, Jaime Roig 11, 46010 Valencia, Spain.
- Neurology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid Autonomous University (IIS-FJD, UAM), 28040 Madrid, Spain.
- Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
ORCID-Profile: Mireia Moreno-Estellés, Manuel Toledo, Pascual Sanz
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- La Fundació La Marató TV3
- Centre for Biomedical Network Research on Rare Diseases
- Programa Prometeo Generalitat Valenciana
- Spanish Ministry of Science and Innovation
- CIBERER
- Prometeo program from Generalitat Valenciana
Zitieren
APA
Moreno-Estellés, M., Machio, M., González, L., Albuixech, M., Abraira, L., Quintana, M., Toledo, M., Sánchez, M. P., Serratosa, J. M., & Sanz, P. (2025). Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115354
Vancouver
Moreno-Estellés M, Machio M, González L, Albuixech M, Abraira L, Quintana M, et al. Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115354
BibTeX
@article{MorenoEstells2025,
author = {Moreno-Estellés, Mireia and Machio, María and González, Laura and Albuixech, Marta and Abraira, Laura and Quintana, Manuel and Toledo, Manuel and Sánchez, Marina P and Serratosa, José M and Sanz, Pascual},
title = {Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115354}
}
EUVIMED